AMANDA BUTCHER: Open Payments
NPI 1497360580 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 25 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $115 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $121 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Exact Sciences Corporation | 3 | $47 |
| Astellas Pharma US Inc | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: NURTEC ODT, The Cologuard Plus Collection Kit, Veozah, ELIQUIS, CAPLYTA, FARXIGA, ROTATEQ, GVOKE HYPOPEN.
Industry payments across MI — which companies pay providers there.
